ABSTRACT
AA arachidonic acid (20:4, n-6) CABG coronary artery bypass graft CAMs cellular adhesion molecules DHA docosahexaenoic acid (22:6, n-3) DM diabetes mellitus EPA eicosapentaenoic acid (20:5, n-3) IHD ischaemic heart disease MI myocardial infarction PCI percutaneous coronary intervention PUFA polyunsaturated fatty acids RCT randomized controlled trial sCAM soluble cellular adhesion molecule
